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Abstract
Aims/hypothesis An earlier meta-analysis showed that dia-
betes is a risk factor for the development and/or recurrence
of depression. Yet whether this risk is different for studies
using questionnaires than for those relying on diagnostic
criteria for depression has not been examined. This study
examined the association of diabetes and the onset of
depression by reviewing the literature and conducting a
meta-analysis of longitudinal studies on this topic.
Methods EMBASE,MEDLINE and PsycInfo were searched
for articles published up to September 2009. All studies that
examined the relationship between type 2 diabetes and the
onset of depression were included. Pooled relative risks were
calculated using fixed and random effects models.
Results Eleven studies met our inclusion criteria for this meta-
analysis. Based on the pooled data, including 48,808 cases of
type 2 diabetes without depression at baseline, the pooled
relative risk was 1.24 (95% CI 1.09–1.40) for the random
effects model. This risk was significantly higher for studies
relying on diagnostic criteria of depression than for studies
using questionnaires. However, this difference was no longer
significant when controlled for year of publication.
Conclusions/interpretation Compared with non-diabetic
controls, people with type 2 diabetes have a 24% increased
risk of developing depression. The mechanisms underlying
this relationship are still unclear and warrant further research.
Keywords Critical review . Depression . Incidence .
Meta-analysis . Systematic review . Type 2 diabetes
Abbreviations
FEM Fixed effects model
MDD Major depressive disorder
REM Random effects model
Introduction
It is now commonly accepted that depressive symptoms and
major depressive disorder (MDD) are twice as prevalent in
individuals with type 2 diabetes [1, 2]. Moreover, psycho-
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logical morbidity in people with diabetes poses huge
challenges for clinical practice. In a recent WHO study,
the greatest decrements in self-reported health were
observed in those with both depression and diabetes, more
so than in those with depression and other chronic
conditions such as angina, arthritis or asthma [3].
Depression has been found to be associated with lower
quality of life [4], poorer diabetes self-care [5], impaired
glycaemic control [6], and an increased risk of developing
diabetes-related complications [7]. Given the higher health-
care expenditure [8] and increased mortality [9, 10]
associated with depression, it is therefore not surprising that
clinical guidelines now recommend that all patients with
diabetes undergo regular screening for depression [11, 12].
It remains unclear, however, whether the presence of
diabetes increases risk for depression, or whether depres-
sion increases risk for diabetes. The early studies in this
area used mainly cross-sectional study designs, which
preclude any causal inferences as to the direction of this
relationship, thus making any recommendations for practice
problematic [1, 2]. More recently, the temporal relationship
between depression and diabetes has been the focus of a
number of longitudinal prospective population-based studies.
Three systematic reviews and meta-analyses [13–15] found
that depression was associated with an increased risk of
incident diabetes. The reverse, that diabetes may be a risk
factor for depression, has been the focus of one earlier
systematic review and meta-analysis, which included seven
studies [15]. It was found that people with type 2 diabetes
had a modest increased risk of developing depression.
However, the authors did not distinguish between studies
that used a diagnosis of a depressive disorder and those that
measured depressive symptoms using self-report measures.
This distinction is important, because high levels of depres-
sive symptoms as measured through self-report question-
naires were found to be more reflective of general emotional
and diabetes-specific distress than of clinical depression
[16, 17]. Therefore, this report examines the relationship
between diabetes and depression by conducting a meta-
analysis of longitudinal studies published on this subject in
the peer-reviewed literature. Moreover, we examined sepa-
rately studies that included a diagnosis of a depressive
disorder and those using self-report measures of depression.
Methods
Retrieval of studies To identify the studies of interest,
MEDLINE (1966 to September 2009), PsycInfo (1872 to
September 2009), and EMBASE (1950 to September 2009)
databases were searched. The search terms are shown in
Electronic supplementary material (ESM) Table 1. Titles
and abstracts of the retrieved studies were scanned to
exclude studies that were clearly irrelevant. The full text
of the remaining studies was then read by three authors
(A. Nouwen, K. Winkley and F. Pouwer), who indepen-
dently determined whether the studies met the inclusion
criteria. Disagreements were solved by a fourth author
(MP), who independently examined the studies, and then
consensus was reached. Furthermore, the reference lists of
articles that studied our topic of interest were scanned to
check for additional publications.
Inclusion/exclusion criteria In this systematic review and
meta-analysis, we included all studies that longitudinally
examined the relationship between type 2 diabetes and onset
of depression, irrespective of their study design. Studies were
excluded if the authors did not explicitly exclude patients with
prevalent depression at baseline or did not control for this
statistically, and if there were insufficient data to estimate a
relative risk (OR, risk ratio or HR). When multiple publica-
tions from the same study population were available, we
included the most recent publication.
Data extraction Three authors (A. Nouwen, F. Pouwer and
C. E. Lloyd) independently extracted data from the studies, in
particular regarding: (1) name of first author, (2) publication
year, (3) study design, (4) follow-up time in years, (5) number
of patients in the analysis, (6) sex of patients, (7) age of
patients, (8) method of depression assessment, (9) method of
diabetes assessment, (10) unadjusted and adjusted relative
risks and 95% CI (adjusted for the largest number of
confounders), (11) confounders adjusted for, (12) method
used for exclusion of depressed patients at baseline, (13)
overall incidence of depression per year.
In the included studies, method of depression assessment
could be either (1) a diagnosis of depression assessed by a
diagnostic psychiatric interview, (2) assessment of depressive
symptoms by a self-reported questionnaire or (3) a diagnosis
by a physician. Studies identified depressed patients at
baseline through either self-report measures or screening, the
latter using a psychiatric diagnostic interview for depression.
Overall incidence per year was extracted as the crude
incidence of depression in the whole study population, divided
by follow-up duration. Type of diabetes could be assessed
through either self-report or screening, i.e. measuring blood
glucose of all patients, or from patients’ medical records.
The quality of the included studies was rated indepen-
dently by two authors (A. Nouwen, K. Winkley) using
criteria for cohort studies from the Centre for Reviews and
Dissemination, University of York, UK [18]. These include
adequacy of the description of groups (type 2 diabetes
mellitus, type 2 diabetes mellitus with depression, control
without depression and control with depression), control for
confounding variables (age, sex, socioeconomic status,
education), blinding of baseline assessment data (diagnosis
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only), description of follow-up data, description of dropout
rates, and comparison of dropout rates between groups on
key variables. Any disagreement was independently
reviewed by a third author (MP) until consensus was
reached.
Statistical analysis Consistently with Mezuk et al. [15], in
each study the relative risk of the model that most closely
adjusted for demographic variables (age, sex, socioeco-
nomic status, marital status) was used to estimate a pooled
OR. Both the fixed effects model (FEM) and the random
effects model (REM) were used. The fixed effects model
assumes that variability between studies is exclusively due
to random variation and individual studies are simply
weighted by their precision. The random effects model
assumes a different underlying effect for each study and
takes this into consideration as an additional source of
variation. A random effects meta-analysis is more conser-
vative than a fixed effects meta-analysis, as it gives wider
CIs around the point estimate, and is recommended when
heterogeneity between studies exists [19]. Because of
expected heterogeneity in the results, we report the results
from only the REMs. A forest plot was made to show the
relative risk and 95% CI of each study and the pooled OR
and 95% CI. Studies reporting HRs were also included. As
the HR provides an underestimation of the OR [20] and the
prevalence of depression is not very high, this underesti-
mation would be small, resulting in a more conservative
estimate of the pooled OR.
To provide visual assessment of publication bias a funnel
plot was drawn, in which the OR was plotted on a logarithmic
scale on the vertical axis against its corresponding standard
error for each study on the horizontal axis. Asymmetry of the
funnel plot is an indicator of publication bias. Publication bias
was also assessed by means of the Begg-adjusted rank
correlation test. To check the influence of publication bias, a
pooled OR was calculated. A forest plot was used to visually
assess homogeneity of the studies. Furthermore, this was
tested with Cochran’s Q test. Finally, the influence of several
aspects of study design on incidence rates was investigated
with meta-regression analysis. Because the number of studies
in the meta-regression is small, we first conducted a set of
bivariate regressions to identify significant correlates for
inclusion in a multiple regression analysis. All statistical
analyses were performed using STATA 10.0 (STATA Corpo-
ration, College Station, TX, USA).
Results
The MEDLINE search identified 385 articles, of which 10
[21–30] met our inclusion criteria and were subsequently
included in the systematic review and meta-analysis (ESM
Fig. 1). The search in EMBASE (total number of studies=
381) identified one additional study [31] meeting the
selection criteria, but no further studies were identified
through the search in PsycInfo (total number of studies=
17). Thus, a total of 19 studies were retrieved for detailed
evaluation, of which 11 studies were selected for inclusion
in the meta-analysis. The extracted data of the 11 studies
included are presented in ESM Table 2. It should be noted
that two studies [23, 24] reported HRs rather than ORs.
Qualitative analysis The results of the quality assessment
of the included studies can be found in ESM Table 3. Only
one study [24] provided adequate description of the four
groups (diabetes depressed, diabetes non-depressed, non-
diabetes depressed, non-diabetes non-depressed) in terms of
confounding variables such as age, sex, number and type of
complications. As such, it was, in most cases, impossible to
see whether the groups were comparable on important
confounding variables. However, most studies (n=8)
controlled statistically for a number of potentially con-
founding variables.
Four studies used diagnostic criteria to determine
depression status [24–26, 30], but none of these studies
reported whether there was any blinding of the assessors to
the status of diabetes. However, as Brown et al. [24] and
O’Connor et al. [31] were retrospective studies and
diagnosis of depression was made by general practitioners
independent of the study rather than by trained assessors,
lack of blinding was deemed less important. However,
reliability of the diagnosis of depression in these two
studies was not reported.
The follow-up time varied between less than 2 years [23]
and 10 years [27]. Two studies [22, 26] combined data from
waves at different time points (2 and 5 years follow-up) to
calculate depression incidence. Finally, while all but two
studies [24, 31] reported the proportion of the cohort that
was followed up, only three studies [21, 22, 25] reported
whether dropout rates and reasons for dropout were similar
across groups. It should be noted that the criteria that were
used for establishing diabetes differed among the studies,
with most relying on doctor’s diagnosis [24, 31] or self-
report of doctor’s diagnosis [22, 23, 25–27]. Others also
used medication use or blood tests such as OGTT or fasting
plasma glucose [21, 27–30] or HbA1c levels [27].
Meta-analysis Based on all studies, including 48,808 cases
of type 2 diabetes, the pooled OR was 1.24 (95% CI 1.09–
1.40). The forest plot of the OR and 95% CI of each study,
and the pooled OR of both the FEM and the REM, are
shown in Fig. 1.
The funnel plot suggested possible publication bias
(Fig. 2). This was also supported by Begg’s adjusted rank
correlation test (p=0.70) and the Egger test (p=0.81).
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The test for heterogeneity was significant (Q=30.84; df=
10; p=0.001), with a moment-based estimate of between
studies variance of 0.021, indicating heterogeneity. We
therefore stratified the studies by method of defining
depression. Among the six studies that relied on question-
naires to define depression, the pooled OR was 1.19 (95%
CI 1.03–1.39) and the test for heterogeneity was not
significant (Q=8.03; df=5; p=0.16), with a moment-based
estimate of between studies variance of 0.013. In the five
studies that defined depression using diagnostic criteria, the
risk of depression was higher than for studies using
questionnaires, with a pooled OR of 1.29 (95% CI 1.05–
1.59). The test for heterogeneity was significant (Q=22.42;
df=4; p<0.001), with a moment-based estimate of between
studies variance of 0.032. However, as one study [24]
relying on diagnostic criteria to define depression included
incident (new) cases of diabetes, the analysis was rerun
without this study. The pooled OR for the four remaining
studies was 1.47 (95% CI 1.34–1.60) and the test for
heterogeneity was not significant (Q=0.91; df=3; p=0.82),
with a moment-based estimate of between studies variance
of 0.00.
Meta-regression Because stratifying by (controlling for)
method of depression measurement (diagnosis or question-
naire) reduced the significant overall study heterogeneity to
non-significance, meta-regression analysis was performed
to examine this further. The results showed that type of
depression measurement (β=−0.25; p<0.001, 95% CI
−0.37, −0.14) was a significant predictor of depression
incidence, with rates higher for studies using diagnostic
criteria to define depression.
Additional meta-analyses were performed to determine
whether other factors might account for the heterogeneity in
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study-specific incidence rates. For example, as can be seen
in Fig. 1, the forest plot showed that the ORs increase over
time, suggesting that the incidence of depression is
increased in more recent studies. Therefore, a set of
single-factor meta-regression analyses was performed with
time since publication, follow-up time, number of follow-
up depression measurements (1 vs >1 or continuous
assessment), sample size, and number of people with
diabetes as separate predictors of depression incidence
OR. The results showed that year of publication (β=0.09;
p<0.001, 95% CI 0.05–0.12) was a significant predictor of
depression incidence OR, but time of follow-up, sample
size, the number of people with diabetes, and number of
follow-up depression measurements were not (p>0.09).
Because type of depression measurement and year of
publication may be confounded, we also examined these
together in a single regression model. The results showed
that year of publication remained significant (β=0.09,
p<0.02, 95% CI 0.02–0.16) but type of depression
measurement was no longer significant (β=−0.07, p<0.95,
95% CI −0.24–0.22). The results did not change when
repeated without Brown et al. [24].
Discussion
The results of this systematic review and meta-analysis of
11 studies involving 172,521 participants, including 48,808
people with type 2 diabetes, show that overall people with
type 2 diabetes have a 24% increased risk of incident
depression compared with people without diabetes. The risk
found in the current study including four more studies is
slightly higher than the one found in an earlier meta-
analysis (OR 1.15, 95% CI 1.02–1.30) [15]. When studies
that used questionnaires to define depression were separated
from those using diagnostic criteria, the odds of incident
depressive symptoms were somewhat lower (OR 1.21) than
the risk of developing incident depressive disorder (OR
1.29). Interestingly, this difference was accentuated when a
study that included incident diabetes rather than prevalent
diabetes [24] was excluded from the analysis; the increased
chance of people with diabetes developing a depressive
disorder was almost 50%. Although the difference in
incidence rates between diagnostic studies and questionnaire
studies was significant, the meta-regression analysis showed
that this effect may have been confounded by higher ORs in
more recent published studies.
Relative to the earlier meta-analysis [15], heterogeneity
was larger in the present meta-analysis. This is primarily a
function of the fact that later studies, those not included in
the earlier analysis, reported higher levels of increased risk
for persons with diabetes. We have no definitive explana-
tion for the apparent increase in incident depression in more
recent studies, although it is possible that both people with
diabetes and healthcare professionals have become increas-
ingly aware of symptoms of depression in diabetes, which
may have led to higher scores at follow-up measurements.
The results of this study should be interpreted cautiously
with regard to whether diabetes is a risk for incident
depression in the strictest sense, i.e. the initial episode of
depression. With the exception of Brown et al. [24], who
excluded participants with depressive episodes within
3 years before the onset of the study, none of the other
studies in this meta-analysis excluded people who had had
depression at some point during a lengthy period before the
onset of the study. Because recurrence of depressive
disorder is high, especially among people with diabetes
[32], the increased incidence of depressive episodes may be
due, in part, to diabetes or stressors related to diabetes
triggering depression more frequently in people with
vulnerability for depression, i.e., people with a history of
depression.
It is possible that the incident depression was associated
with the development of diabetes-related complications. For
example, the Brown et al. [24] study only included people
with incident diabetes, and the likelihood of diabetes-
related complications is likely to be lower in this sample.
Interestingly, in this study the risk of developing depression
was increased in people with cerebrovascular disease and
peripheral arterial disease but not in those with coronary
artery disease. de Jonge et al. [26] found that the
longitudinal association of diabetes and depression was
reduced after controlling for other chronic somatic diseases
and was no longer significant. These findings are consistent
with the results of two large cross-sectional studies [33, 34]
showing that the prevalence of depressive disorder was
higher in diabetes patients with diabetes-related complica-
tions, especially cardiovascular disease, than in those
without complications.
The increased incidence rate for depression in people
with type 2 diabetes found in the current meta-analysis (OR
1.19– 1.47) contrasts with a two-fold increase in the
prevalence rate of depression (OR 2.0) found in a previous
meta-analysis [1]. This is likely to be a result of two distinct
processes. First, because prevalence is a function of not
only incidence but also duration, the prevalence of a
chronic condition such as depression is higher than one
might expect based on the incidence rate alone. This line of
reasoning is supported by earlier reports that, among people
with diabetes, episodes of MDD last longer and are more
recurrent [32, 35]. Our finding that the risk in diabetes of
developing depressive disorder is greater than that of
developing depressive symptoms is consistent with this.
In addition, because depression is a risk factor for the
development of diabetes [13], relatively more people with
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diabetes would have a history of depression and as such an
increased risk of developing a further episode.
This study has several limitations. First, measures of
depression varied among studies. We were able to examine
several aspects of this variation, finding that few factors
were associated with study-specific levels of diabetes risk.
However, there was substantial variation among studies
using a particular form of depression measurement. Among
the studies that used diagnostic criteria for the assessment
of depression, two relied on the clinical judgement of
general practitioners to establish a diagnosis while the other
two used formal diagnostic interview schedules with trained
researchers. Among studies using self-report questionnaires
to assess depressive symptoms, different questionnaires and
different cut-off values were used to define cases of
depression. Because self-reported depressive symptoms in
people with diabetes have been found to be indicative of
general emotional and diabetes-specific distress rather than
depressive disorder [16], the questionnaire studies, espe-
cially those with lower cut-off values, may have resulted in
an over-estimation of the incidence rate of clinically
significant levels of depression in people with diabetes. In
addition, some studies also included antidepressant medi-
cation use as a stand-alone proxy measure of depression
[24, 28, 29, 31]. However, because antidepressant medica-
tion is prescribed for other problems, such as neuropathic
pain [36, 37] or sedation, this also may have artificially
increased the incidence rate, particularly among people with
diabetes. Finally, a number of studies [21, 27] used
different measures or cut-off values at baseline than at
follow-up, which may have led to misclassification of cases
of depression at baseline and therefore affected the
incidence rates for depression.
Another limitation is that the majority of the studies
analysed here limited the assessment of incident depression
to a single follow-up at a distinct time point, and none
assessed the onset and offset of depressive episodes; thus
these studies provide no insight into the temporal dynamics
of the episodes.
Finally, the relatively small number of studies available
for analysis limited our ability to examine the independent
contribution of multiple methodological factors in accounting
for the between-study variation in diabetes-related risk for
depression.
Conclusion
Overall, the results from this meta-analysis suggest that the
risk of a new depressive episode is higher among people
with type 2 diabetes than in the general population. This
increased risk may be greater among people who have
suffered a previous depressive episode or who have
diabetes-related complications. Moreover, the risk of
incident depression associated with diabetes appears to be
increasing over time. Because of the negative consequences
of depression in diabetes, such as poorly controlled diabetes
[6], an increased risk of complications [7], higher mortality
[10] and increased healthcare costs [8], it is important that
these vulnerable groups should be screened regularly for
depression. We would further suggest that such efforts
should be incorporated into treatment programmes for
depression [38].
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